MTX-531
Pre-clinical- Indications
- Head and neck cancer
Company intelligence / Profile preview
Invenshure
Minneapolis, Minnesota, United Statesinvenshure.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Other
01
Overview
Invenshure does not conduct clinical trials itself but launches and accelerates biotech startups. For example, its spinout MEKanistic Therapeutics has shown preclinical efficacy with reduced toxicity in tumor models and aims for IND approval with Phase 1 trials anticipated soon. No direct clinical results attributable to the parent entity.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Investors
02
Drug pipeline
1 asset03
Partnerships
Leading scientists/institutionsImbio/Flywheel Exchange (under Invenshure umbrella)
Beyond the preview
Go deeper on Invenshure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Invenshure.